Biotech industry will continue to consolidate, sector analyst says

Alex Arfaei, pharmaceutical analyst from BMO Capital Markets Corp, joins "Squawk Box" with his analysis on where the biotech sector is headed following the Bristol-Myers Squibb's acquisition of Celgene.
05:09
Fri, Jan 4 20196:28 AM EST